July 1, 2024 - Page 12 of 12

NASDAQ Companies - July 1, 2024

Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week

NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]

5 6 7 8 9 10 1112

page 12 of 12

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search